Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection.
about
Engineered Viruses as Genome Editing DevicesAntimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosisPolymicrobial infection and bacterium-mediated epigenetic modification of DNA tumor viruses contribute to pathogenesisHuman immunodeficiency virus type 1 Vpu and cellular TASK proteins suppress transcription of unintegrated HIV-1 DNA.Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery.Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene EditingAAV exploits subcellular stress associated with inflammation, endoplasmic reticulum expansion, and misfolded proteins in models of cystic fibrosis.Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer.Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application.Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector.Short chain fatty acids potently induce latent HIV-1 in T-cells by activating P-TEFb and multiple histone modifications.Comparison Between Several Integrase-defective Lentiviral Vectors Reveals Increased Integration of an HIV Vector Bearing a D167H Mutant.Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomesHepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic riskThe HIV-1 Rev/RRE system is required for HIV-1 5' UTR cis elements to augment encapsidation of heterologous RNA into HIV-1 viral particles.The role of unintegrated DNA in HIV infectionIntegrase inhibitor reversal dynamics indicate unintegrated HIV-1 dna initiate de novo integration.Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligandsMuLV IN mutants responsive to HDAC inhibitors enhance transcription from unintegrated retroviral DNA.Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors.Methods for gene transfer to the central nervous system.HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.Opposite transcriptional regulation of integrated vs unintegrated HIV genomes by the NF-κB pathway.Impact of periodontal intervention on local inflammation, periodontitis, and HIV outcomes.Effects of Succinic Acid and Other Microbial Fermentation Products on HIV Expression in MacrophagesThe role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract.Hematopoietic Stem cell transplantation and lentiviral vector-based gene therapy for Krabbe's disease: Present convictions and future prospects.An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases.A systematic comparison reveals substantial differences in chromosomal versus episomal encoding of enhancer activity.Integration-deficient lentiviral vectors expressing codon-optimized R338L human FIX restore normal hemostasis in Hemophilia B mice.Distribution and fate of HIV-1 unintegrated DNA species: a comprehensive updateHybrid lentiviral vectors.Enteric pathogen exploitation of the microbiota-generated nutrient environment of the gut.Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity.Targeted gene therapies: tools, applications, optimizationTotal HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.Different Pathways Leading to Integrase Inhibitors ResistanceUnderlying mechanisms of HIV-1 latency.Reactivation of latent HIV-1 by a wide variety of butyric acid-producing bacteria.
P2860
Q26785927-B703AC67-A45F-442D-86FD-88018B6DBBF0Q28081831-2B688C1B-963E-4916-ADCD-8FAA8180080AQ28657924-6B51D23D-1D93-427F-BD66-1FD08E17C4F1Q30422793-8E4E2709-40A7-444C-80F8-3E39A4182DA7Q33633293-3D15747B-D7F0-4497-8EF7-63BE29F5145AQ33655722-7A7F3EEE-497F-434F-A541-0D797F9781EFQ33916501-CD4EB4D8-296D-4931-9807-C113DF7A6A62Q34137546-BE942E39-16C7-46B8-B639-C1FD74CEBB20Q34343763-7DFCC39D-8886-4FF1-B0ED-8C8087859B53Q34621737-B3C917C3-3538-4FDF-9035-63FCAFF0BD61Q34656952-AA169085-4C50-4C84-B980-2F29D14CF2FDQ34745316-B178D9C9-8A9A-4A58-90F7-4998C5DE6481Q34998226-8BED749E-DD59-486C-99BB-023350A30B3FQ35038004-4D7A6463-6BE9-444D-8F2F-39025753EE1DQ35090661-34DD396F-0365-4628-9360-7B47526F313AQ35143730-CAEEB46F-4F17-4401-AA62-F25D8EB5DC5CQ35213243-678E2C37-65C4-4AE6-B765-734DBA3B2CEFQ35784465-C960D3CF-A81C-4A7F-A8A7-8DDEFCD29407Q35803106-E4398A8F-0C24-46D1-BD3E-53A8C6CDADF6Q35878409-D6904DC7-4C41-4317-A453-9F3F017A8F3AQ35902332-702EDD3E-18EB-41A1-9A1B-C9837219E246Q36428308-E779C9A4-C72E-4239-93D3-C3350DA7CE1FQ36890640-7DE7731C-693A-4F6B-89F0-8B6269A7C039Q36986302-11D98601-CD05-44DE-83B7-8A8A0F8BE2E6Q37181344-71E38415-E6C8-4817-8F24-7157134CFE1AQ37210863-4515B859-9984-4E16-8B1F-553B6903AAF7Q37265523-F28B96A9-D9BA-43F7-AF78-157F0EEF0A93Q37336473-C017D6AB-647F-47F7-8EDE-5D5F5A10E08BQ37406920-FF7276FC-F2A1-41AA-A03B-3F723C160F4DQ37548504-749A6E20-04A6-4F14-AD6B-C8D284113700Q37620808-E4808EA8-8073-43BB-8A95-64B06442B56CQ37649116-B3BAEEEB-7EED-4C8D-A571-82CC29B195D8Q37734854-C2DA0338-9481-4D1E-BEEA-606DCA1AFD5EQ37826861-58A3365E-1E9F-4787-853D-2C6EF423594EQ37857291-C0BCAEC3-7CFB-453A-BAE3-CD854569A936Q38005211-66FFEB16-CE87-4C1D-82CE-46D0A6E409EFQ38936786-6718624F-466C-4080-B61B-C632FAC486C4Q39103603-717BA5FD-C325-4697-9D0B-2F17128A0A61Q39160623-58CAD5D7-37AE-4A62-AFB8-4E8D47C63DBAQ39398757-72B03668-B621-496C-8EF3-C1ED1A5C8708
P2860
Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epigenetic activation of unint ...... mplications for HIV infection.
@en
Epigenetic activation of unint ...... mplications for HIV infection.
@nl
type
label
Epigenetic activation of unint ...... mplications for HIV infection.
@en
Epigenetic activation of unint ...... mplications for HIV infection.
@nl
prefLabel
Epigenetic activation of unint ...... mplications for HIV infection.
@en
Epigenetic activation of unint ...... mplications for HIV infection.
@nl
P2093
P2860
P356
P1476
Epigenetic activation of unint ...... mplications for HIV infection.
@en
P2093
Boris Kantor
Jennifer Webster-Cyriaque
Paul E Monahan
P2860
P304
18786-18791
P356
10.1073/PNAS.0905859106
P407
P577
2009-10-20T00:00:00Z